Medical Devices Investors & VC Firms in North America
1074 firms in this list, with a median first check of $500K. 236 of them lead rounds. Generated from verified public data and updated continuously.
American Century Private Investments
Kansas CityGrowth
20 people
InterGen Capital
CalgarySeed–Growth
17 people
JLS
New YorkSeed–Series B
14 people
Alix Ventures
San FranciscoSeed–Series A$100K – $500K
13 people
Equitage Ventures, L.L.C.
DenverSeed–Series A$250K – $2.5M
10 people
Magnetic Ventures
BostonSeed–Series A$1M – $6M
9 people
3E Bioventures Capital
Palo AltoSeed–Series A
5 people
Pallasite Ventures
VancouverSeed–Series A$100K – $1.5M
1 person
VSC Ventures
San FranciscoPre-Seed–Seed$500K – $750K
10 people
Catalyst Health Ventures
BostonSeed–Series A$1M – $3M
9 people
Cressey & Company
ChicagoGrowth
18 people
InFocus Capital Partners, LLC
JerichoSeed–Series A
18 people
Nueterra Capital
LeawoodSeed–Late Stage
6 people
Time BioVentures
Southern CaliforniaSeed–Series A
15 people
AMR Action Fund
BostonSeed–Growth
13 people
Birchmere Ventures
PittsburghSeed–Series A$500K – $5M
4 people
California Technology Ventures
PasadenaSeed–Series A$250K – $2M
3 people
Methuselah Foundation
SpringfieldSeed
16 people
MC Healthcare Ventures
CambridgeSeed–Series A
6 people
DigiTx Partners LLC
San FranciscoSeed–Series A$2M – $5M
8 people
Foreground Capital
BostonSeed–Series B
8 people
iNetworks
PittsburghSeed–Late Stage
11 people
Coddle Creek Capital
KannapolisPre-Seed–Seed$150K – $650K
16 people
First In Ventures
MiddletownPre-Seed–Seed$50K – $200K
7 people
Related lists
Investors & VC Firms in North America (13518)Investors & VC Firms in United States (12555)Investors & VC Firms in Europe (5846)Investors & VC Firms in Global (4720)AI & Machine Learning Investors & VC Firms (4549)Fintech Investors & VC Firms (4537)SaaS Investors & VC Firms (4215)Healthtech Investors & VC Firms (4185)Enterprise Software Investors & VC Firms (4097)Crypto & Web3 Investors & VC Firms (3965)
Data sourced from public filings and firms' own websites — see our methodology.
























)
)
)

































































